COLITIS, ULCERATIVE
Clinical trials for COLITIS, ULCERATIVE explained in plain language.
Never miss a new study
Get alerted when new COLITIS, ULCERATIVE trials appear
Sign up with your email to follow new studies for COLITIS, ULCERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for ulcerative colitis: phase 3 trial launches
Disease control Not yet recruitingThis study tests a new medicine called JNJ-78934804 against an existing drug (guselkumab) in 644 people with moderate to severe ulcerative colitis, a chronic condition causing colon inflammation and ulcers. The goal is to see if the new drug can bring about remission—meaning less…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 17, 2026 00:29 UTC
-
New study tracks how long IBD drug guselkumab lasts in real life
Disease control Not yet recruitingThis study will follow 50 people with moderate to severe Crohn's disease or ulcerative colitis to see how long the drug guselkumab keeps working in everyday medical practice. Researchers will measure how long patients stay on the treatment and how quickly they feel better. The go…
Matched conditions: COLITIS, ULCERATIVE
Sponsor: Janssen-Cilag A.G., Switzerland • Aim: Disease control
Last updated May 17, 2026 00:28 UTC
-
New drug balinatunfib tested for long-term safety in inflammatory bowel disease
Disease control Not yet recruitingThis study looks at the long-term safety of a drug called balinatunfib in adults with Crohn's disease or ulcerative colitis. Participants have already completed a one-year study with the drug or a placebo. The goal is to see if the drug is safe over a longer period, up to about t…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New hope for inflammatory bowel disease: multiple treatments enter testing
Disease control Not yet recruitingThis study is testing several different new treatments for adults with moderate to severe ulcerative colitis or Crohn's disease. Participants will be assigned to one of the specific treatment studies and receive either the new treatment or a comparison treatment for at least 62 w…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Apr 23, 2026 12:44 UTC
-
Good viruses in your gut: could they be the key to taming IBD?
Knowledge-focused Not yet recruitingThis study looks at the viruses (called bacteriophages) living in the guts of people with inflammatory bowel disease (IBD) and healthy people. Researchers want to understand how these viruses differ and whether they can be grown in a lab to create a future treatment. No treatment…
Matched conditions: COLITIS, ULCERATIVE
Sponsor: Andreas Munk Petersen • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC